-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Purpose: As of September 14, 2021, there are nearly 220 million confirmed cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) worldwide, and nearly 4.
6 million people have died
.
Although unprecedented efforts have been made in the sequencing, diagnosis, treatment, and prevention of COVID-19, the long-term sequelae of COVID-19 have not yet been fully elucidated
In conclusion, among COVID-19 patients followed up for 1 year, 25% (53 of 209 cases) showed abnormalities on chest CT; abnormalities include chronic fibrosis-like (linear [25/209,12%] or multifocal network And/or cystic [28/209, 13%]) lesions
.
Elderly patients with severe COVID-19 or adult respiratory distress syndrome (ARDS) are more likely to have lung sequelae
Elderly patients with severe COVID-19 or adult respiratory distress syndrome (ARDS) are more likely to have lung sequelae
A one-year follow-up CT scan of patients recovering from new coronary pneumonia showed chronic fibrosis-like linear or multifocal reticulum/cystic lesions.
Lee KS, Wi YM, Residual Lung Lesions at 1-year CT after COVID-19.
Residual Lung Lesions at 1-year CT after COVID-19.
Leave a message here
